CUSIP: 07160F107
Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,030,136
-
Share change
-
+5,029,836
-
Total reported value
-
$34,782,000
-
Price per share
-
$6.92
-
Number of holders
-
58
-
Value change
-
+$34,779,999
-
Number of buys
-
57
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 07160F107:
Institutional Holders of BAUDAX BIO INC - COM (BXRX) as of Q4 2019
As of 31 Dec 2019,
BAUDAX BIO INC - COM (BXRX) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,030,136 shares.
The largest 10 holders included
CORSAIR CAPITAL MANAGEMENT, L.P., BlackRock Inc., Engine Capital Management, LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Newtyn Management, LLC, NORTH RUN CAPITAL, LP, PANAGORA ASSET MANAGEMENT INC, Northern Right Capital Management, L.P., and STATE STREET CORP.
This page lists
58
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.